$2M grant awarded to study drug’s impact on Alzheimer’s patients

August 25, 2020

In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]

Alzheimers written in wooden cubes




Research shows new education program may increase hepatitis C screenings

August 10, 2020

A team of researchers from UT Health San Antonio and UT Southwestern have published a study in the Journal of Cancer Education showing that a new, shortened training program for health care providers may increase screenings for hepatitis C virus (HCV) across the region.




Third remdesivir study begins

August 7, 2020

UT Health San Antonio and its clinical partner University Health System are on the front lines working to find new treatments for COVID-19.